Skip to the page

Data / Form D filings / Paxos Labs Inc.

Paxos Labs Inc.: Form D filing

Paxos Labs Inc., a company in New York, NY, filed a Form D with the SEC in 2026. The latest, on January 9, 2026, reports $10.5 million sold of a $12 million offering to 43 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
169 MADISON AVENUE, SUITE 38260, New York, NY, 10016
Phone
(408) 673-7616
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2097647

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 9, 2026New notice$12,009,144$10,508,944$1,500,20043Dec 30, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Bhaumik KotechaExecutive Officer, Director
Charles CascarillaExecutive Officer, Director
Yuan Han LiDirector

Other companies in New York that filed recently

Every Form D from the week of Jan 5, 2026 · All recent filings in New York · All recent Other filings

Read from SEC EDGAR. Amount sold is what Paxos Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.